St. Jude Medical Announces FDA Approval Of Epic Stented Tissue Valve With Anti-Calcification Technology

St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of its Epic(TM) Stented Tissue Valve with Linx(TM) AC Technology. Identical in design to the company’s Biocor(TM) Valve, which currently leads the tissue valve industry in U.S. market share growth, the Epic Valve also incorporates patented anti-calcification technology designed to protect against tissue mineralization, or hardening. [click link for full article]

More: continued here

Filed under: Cardiovascular on December 2nd, 2007